Authors: GNATENKO D ARNOLD TE ZOLOTUKHIN S NUOVO GJ MUZYCZKA N BAHOU WF

Citation: D. Gnatenko et al., CHARACTERIZATION OF RECOMBINANT ADENOASSOCIATED VIRUS-2 AS A VEHICLE FOR GENE DELIVERY AND EXPRESSION INTO VASCULAR CELLS, Journal of investigative medicine, 45(2), 1997, pp. 87-98

Authors: ARNOLD TE GNATENKO D BAHOU WF

Citation: Te. Arnold et al., IN-VIVO GENE-TRANSFER INTO RAT ARTERIAL-WALLS WITH NOVEL ADENOASSOCIATED VIRUS VECTORS, Journal of vascular surgery, 25(2), 1997, pp. 347-355

Authors: GNATENKO D JESTY J HEARING P SAENKO E BAHOU WF

Citation: D. Gnatenko et al., RECOMBINANT ADENOASSOCIATED VIRUS AS A VEHICLE FOR GENE DELIVERY OF HUMAN MUTANT FACTOR-VIII, Blood, 90(10), 1997, pp. 518-518

Authors: GNATENKO D ARNOLD T ZOLOTUKHIN S MUZYCZKA N BAHOU W

Citation: D. Gnatenko et al., RECOMBINANT ADENOASSOCIATED VIRUS-2 (RAAV) AS A VECTOR FOR GENE DELIVERY INTO VASCULAR CELLS, Journal of investigative medicine, 44(3), 1996, pp. 319-319

Authors: GNATENKO D HEARING P GERGEL J JESTY J BAHOU W

Citation: D. Gnatenko et al., GENERATION AND CHARACTERIZATION OF RECOMBINANT ADENOASSOCIATED VIRAL (RAAV) VECTORS FOR FACTOR-VIII GENE-THERAPY, Blood, 88(10), 1996, pp. 543-543

Authors: GNATENKO D MUZYCZKA N ZOLOTUKHIN S BAHOU W

Citation: D. Gnatenko et al., ADENOASSOCIATED VIRUS-2 (AAV) AS A VEHICLE FOR GENE DELIVERY INTO VASCULAR ENDOTHELIAL-CELLS, Blood, 84(10), 1994, pp. 10000741-10000741